Zejula (niraparib) is a prescription drug that’s used to treat ovarian cancer. Zejula comes as an oral tablet or capsule. Zejula is prescribed for adults who have epithelial cancer of the ovaries, ...
How Does Zejula Work in Advanced Ovarian Cancer? In platinum-based chemotherapy, the platinum in the medicine binds to the genetic material (DNA) of cancer cells. This damages the cancer cells and ...
Zejula (niraparib) is a brand-name drug that’s prescribed for certain types of cancer in adults. Zejula comes as a tablet that’s typically taken once per day. The dosage can vary depending on what ...
Frontline Zejula maintenance therapy decreased the risk of disease progression or death in patients with newly diagnosed ovarian cancer. Upfront maintenance therapy with Zejula (niraparib) decreased ...
Meaningful improvements in survival were obtained with Zejula maintenance therapy compared with placebo in patients with advanced ovarian cancer that was newly diagnosed. Patients with newly diagnosed ...
ZEJULA is the first and only PARP inhibitor to be approved for the maintenance treatment of women with recurrent ovarian cancer ZEJULA is the only PARP inhibitor that has demonstrated a clinically ...
ESMO: GSK's Zejula misses survival goal in first-line ovarian cancer, as pharma&'s combo disappoints
In a rough day for PARP inhibitors in ovarian cancer, GSK’s Zejula didn’t deliver a life extension benefit in the final analysis of a phase 3 trial. Another study showed that pharma&’s attempt to ...
SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...
SHANGHAI, China and SAN FRANCISCO, Dec. 27, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results